Advertisement

Analgesia Targeting IB4-Positive Neurons in Cancer-Induced Mechanical Hypersensitivity

      Abstract

      Cancer patients often suffer from pain and most will be prescribed μ-opioids. μ-opioids are not satisfactory in treating cancer pain and are associated with multiple debilitating side effects. Recent studies show that μ and δ opioid receptors are separately expressed on IB4 (−) and IB4 (+) neurons, which control thermal and mechanical pain, respectively. In this study we investigated IB4 (+) and IB4 (−) neurons in mechanical and thermal hypersensitivity in an orthotopic mouse oral cancer model. We used a δ opioid receptor agonist and a P2X3 antagonist to target IB4 (+) neurons and to demonstrate that this subset plays a key role in cancer-induced mechanical allodynia, but not in thermal hyperalgesia. Moreover, selective removal of IB4 (+) neurons using IB4-saporin impacts cancer-induced mechanical but not thermal hypersensitivity. Our results demonstrate that peripherally administered pharmacological agents targeting IB4 (+) neurons, such as a selective δ-opioid receptor agonist or P2X3 antagonist, might be useful in treating oral cancer pain.

      Perspective

      To clarify the mechanisms of oral cancer pain, we examined the differential role of IB4 (+) and IB4 (−) neurons. Characterization of these 2 subsets of putative nociceptors is important for further development of effective clinical cancer pain relief.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Adriaenssens E.
        • Vanhecke E.
        • Saule P.
        • Mougel A.
        • Page A.
        • Romon R.
        • Nurcombe V.
        • Le Bourhis X.
        • Hondermarck H.
        Nerve growth factor is a potential therapeutic target in breast cancer.
        Cancer Res. 2008; 68: 346-351
        • Albers K.M.
        • Davis B.M.
        The skin as a neurotrophic organ.
        Neuroscientist. 2007; 13: 371-382
        • Albers K.M.
        • Woodbury C.J.
        • Ritter A.M.
        • Davis B.M.
        • Koerber H.R.
        Glial cell-line-derived neurotrophic factor expression in skin alters the mechanical sensitivity of cutaneous nociceptors.
        J Neurosci. 2006; 26: 2981-2990
        • Bennett D.L.
        • Koltzenburg M.
        • Priestley J.V.
        • Shelton D.L.
        • McMahon S.B.
        Endogenous nerve growth factor regulates the sensitivity of nociceptors in the adult rat.
        Eur J Neurosci. 1998; 10: 1282-1291
        • Bennett D.L.
        • Michael G.J.
        • Ramachandran N.
        • Munson J.B.
        • Averill S.
        • Yan Q.
        • McMahon S.B.
        • Priestley J.V.
        A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury.
        J Neurosci. 1998; 18: 3059-3072
        • Bergmann I.
        • Reiter R.
        • Toyka K.V.
        • Koltzenburg M.
        Nerve growth factor evokes hyperalgesia in mice lacking the low-affinity neurotrophin receptor p75.
        Neurosci Lett. 1998; 255: 87-90
        • Bogen O.
        • Joseph E.K.
        • Chen X.
        • Levine J.D.
        GDNF hyperalgesia is mediated by PLCgamma, MAPK/ERK, PI3K, CDK5 and Src family kinase signaling and dependent on the IB4-binding protein versican.
        Eur J Neurosci. 2008; 28: 12-19
        • Bradbury E.J.
        • Burnstock G.
        • McMahon S.B.
        The expression of P2X3 purinoreceptors in sensory neurons: Effects of axotomy and glial-derived neurotrophic factor.
        Mol Cell Neurosci. 1998; 12: 256-268
        • Brainin-Mattos J.
        • Smith N.D.
        • Malkmus S.
        • Rew Y.
        • Goodman M.
        • Taulane J.
        • Yaksh T.L.
        Cancer-related bone pain is attenuated by a systemically available delta-opioid receptor agonist.
        Pain. 2006; 122: 174-181
        • Breese N.M.
        • George A.C.
        • Pauers L.E.
        • Stucky C.L.
        Peripheral inflammation selectively increases TRPV1 function in IB4-positive sensory neurons from adult mouse.
        Pain. 2005; 115: 37-49
        • Breivik H.
        Opioids in cancer and chronic non-cancer pain therapy – indications and controversies.
        Acta Anaesthesiol Scand. 2001; 45: 1059-1066
        • Cavanaugh D.J.
        • Lee H.
        • Lo L.
        • Shields S.D.
        • Zylka M.J.
        • Basbaum A.I.
        • Anderson D.J.
        Distinct subsets of unmyelinated primary sensory fibers mediate behavioral responses to noxious thermal and mechanical stimuli.
        Proc Natl Acad Sci U S A. 2009; 106: 9075-9080
        • Cheng P.Y.
        • Wu D.
        • Decena J.
        • Soong Y.
        • McCabe S.
        • Szeto H.H.
        Opioid-induced stimulation of fetal respiratory activity by [D-Ala2]deltorphin I.
        Eur J Pharmacol. 1993; 230: 85-88
        • Christo P.J.
        • Mazloomdoost D.
        Cancer pain and analgesia.
        Ann N Y Acad Sci. 2008; 1138: 278-298
        • Codd E.E.
        • Carson J.R.
        • Colburn R.W.
        • Stone D.J.
        • Van Besien C.R.
        • Zhang S.P.
        • Wade P.R.
        • Gallantine E.L.
        • Meert T.F.
        • Molino L.
        • Pullan S.
        • Razler C.M.
        • Dax S.L.
        • Flores C.M.
        JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence.
        J Pharmacol Exp Ther. 2009; 329: 241-251
        • Connelly S.T.
        • Schmidt B.L.
        Evaluation of pain in patients with oral squamous cell carcinoma.
        J Pain. 2004; 5: 505-510
        • Cowan A.
        • Zhu X.Z.
        • Mosberg H.I.
        • Omnaas J.R.
        • Porreca F.
        Direct dependence studies in rats with agents selective for different types of opioid receptor.
        J Pharmacol Exp Ther. 1988; 246: 950-955
        • Dirajlal S.
        • Pauers L.E.
        • Stucky C.L.
        Differential response properties of IB(4)-positive and -negative unmyelinated sensory neurons to protons and capsaicin.
        J Neurophysiol. 2003; 89: 513-524
        • Dyck P.J.
        • Peroutka S.
        • Rask C.
        • Burton E.
        • Baker M.K.
        • Lehman K.A.
        • Gillen D.A.
        • Hokanson J.L.
        • O’Brien P.C.
        Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans.
        Neurology. 1997; 48: 501-505
        • Epstein J.B.
        • Elad S.
        • Eliav E.
        • Jurevic R.
        • Benoliel R.
        Orofacial pain in cancer: Part II–clinical perspectives and management.
        J Dent Res. 2007; 86: 506-518
        • Fang X.
        • Djouhri L.
        • McMullan S.
        • Berry C.
        • Waxman S.G.
        • Okuse K.
        • Lawson S.N.
        Intense isolectin-B4 binding in rat dorsal root ganglion neurons distinguishes C-fiber nociceptors with broad action potentials and high Nav1.9 expression.
        J Neurosci. 2006; 26: 7281-7292
        • Golden J.P.
        • Hoshi M.
        • Nassar M.A.
        • Enomoto H.
        • Wood J.N.
        • Milbrandt J.
        • Gereau R.W.I.V.
        • Johnson Jr., E.M.
        • Jain S.
        RET signaling is required for survival and normal function of nonpeptidergic nociceptors.
        J Neurosci. 2010; 30: 3983-3994
        • Halvorson K.G.
        • Kubota K.
        • Sevcik M.A.
        • Lindsay T.H.
        • Sotillo J.E.
        • Ghilardi J.R.
        • Rosol T.J.
        • Boustany L.
        • Shelton D.L.
        • Mantyh P.W.
        A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone.
        Cancer Res. 2005; 65: 9426-9435
        • Honore P.
        • Mikusa J.
        • Bianchi B.
        • McDonald H.
        • Cartmell J.
        • Faltynek C.
        • Jarvis M.F.
        TNP-ATP, a potent P2X3 receptor antagonist, blocks acetic acid-induced abdominal constriction in mice: Comparison with reference analgesics.
        Pain. 2002; 96: 99-105
        • Joseph E.K.
        • Chen X.
        • Bogen O.
        • Levine J.D.
        Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.
        J Pain. 2008; 9: 463-472
        • Joseph E.K.
        • Levine J.D.
        Mu and delta opioid receptors on nociceptors attenuate mechanical hyperalgesia in rat.
        Neuroscience. 2010; 171: 344-350
        • Kerr B.J.
        • Souslova V.
        • McMahon S.B.
        • Wood J.N.
        A role for the TTX-resistant sodium channel Nav 1.8 in NGF-induced hyperalgesia, but not neuropathic pain.
        Neuroreport. 2001; 12: 3077-3080
        • Kolokythas A.
        • Cox D.P.
        • Dekker N.
        • Schmidt B.L.
        Nerve growth factor (NGF) and tyrosine kinase A (Trk A) receptor in oral squamous cell carcinoma: Is there an association with perineural invasion?.
        J Oral Maxillofac Surg. 2010; 68: 1290-1295
        • Lam D.K.
        • Schmidt B.L.
        Serine proteases and protease-activated receptor 2-dependent allodynia: A novel cancer pain pathway.
        Pain. 2010; 149: 263-272
        • Le Bourdonnec B.
        • Windh R.T.
        • Leister L.K.
        • Zhou Q.J.
        • Ajello C.W.
        • Gu M.
        • Chu G.H.
        • Tuthill P.A.
        • Barker W.M.
        • Koblish M.
        • Wiant D.D.
        • Graczyk T.M.
        • Belanger S.
        • Cassel J.A.
        • Feschenko M.S.
        • Brogdon B.L.
        • Smith S.A.
        • Derelanko M.J.
        • Kutz S.
        • Little P.J.
        • DeHaven R.N.
        • DeHaven-Hudkins D.L.
        • Dolle R.E.
        Spirocyclic delta opioid receptor agonists for the treatment of pain: Discovery of N, N-diethyl-3-hydroxy-4-(spiro[chromene-2,4’-piperidine]-4-yl) benzamide (ADL5747).
        J Med Chem. 2009; 52: 5685-5702
        • Lin J.
        • Li G.
        • Den X.
        • Xu C.
        • Liu S.
        • Gao Y.
        • Liu H.
        • Zhang J.
        • Li X.
        • Liang S.
        VEGF and its receptor-2 involved in neuropathic pain transmission mediated by P2X2/3 receptor of primary sensory neurons.
        Brain Res Bull. 2010; 83: 284-291
        • Lindfors P.H.
        • Voikar V.
        • Rossi J.
        • Airaksinen M.S.
        Deficient nonpeptidergic epidermis innervation and reduced inflammatory pain in glial cell line-derived neurotrophic factor family receptor alpha2 knock-out mice.
        J Neurosci. 2006; 26: 1953-1960
        • Malik-Hall M.
        • Dina O.A.
        • Levine J.D.
        Primary afferent nociceptor mechanisms mediating NGF-induced mechanical hyperalgesia.
        Eur J Neurosci. 2005; 21: 3387-3394
        • Mantyh W.G.
        • Jimenez-Andrade J.M.
        • Stake J.I.
        • Bloom A.P.
        • Kaczmarska M.J.
        • Taylor R.N.
        • Freeman K.T.
        • Ghilardi J.R.
        • Kuskowski M.A.
        • Mantyh P.W.
        Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain.
        Neuroscience. 2010; 171: 588-598
        • Mogil J.S.
        • Breese N.M.
        • Witty M.F.
        • Ritchie J.
        • Rainville M.L.
        • Ase A.
        • Abbadi N.
        • Stucky C.L.
        • Seguela P.
        Transgenic expression of a dominant-negative ASIC3 subunit leads to increased sensitivity to mechanical and inflammatory stimuli.
        J Neurosci. 2005; 25: 9893-9901
        • Molliver D.C.
        • Radeke M.J.
        • Feinstein S.C.
        • Snider W.D.
        Presence or absence of TrkA protein distinguishes subsets of small sensory neurons with unique cytochemical characteristics and dorsal horn projections.
        J Comp Neurol. 1995; 361: 404-416
        • Molliver D.C.
        • Wright D.E.
        • Leitner M.L.
        • Parsadanian A.S.
        • Doster K.
        • Wen D.
        • Yan Q.
        • Snider W.D.
        IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life.
        Neuron. 1997; 19: 849-861
        • Moore B.A.
        • Albers K.M.
        • Davis B.M.
        • Grandis J.R.
        • Togel S.
        • Bauer A.J.
        Altered inflammatory gene expression underlies increased susceptibility to murine postoperative ileus with advancing age.
        Am J Physiol Gastrointest Liver Physiol. 2007; 292: G1650-G1659
        • Pacheco D.F.
        • Duarte I.D.
        Delta-opioid receptor agonist SNC80 induces peripheral antinociception via activation of ATP-sensitive K+ channels.
        Eur J Pharmacol. 2005; 512: 23-28
        • Pacheco D.F.
        • Reis G.M.
        • Francischi J.N.
        • Castro M.S.
        • Perez A.C.
        • Duarte I.D.
        Delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway.
        Life Sci. 2005; 78: 54-60
        • Park C.K.
        • Kim M.S.
        • Fang Z.
        • Li H.Y.
        • Jung S.J.
        • Choi S.Y.
        • Lee S.J.
        • Park K.
        • Kim J.S.
        • Oh S.B.
        Functional expression of thermo-transient receptor potential channels in dental primary afferent neurons: Implication for tooth pain.
        J Biol Chem. 2006; 281: 17304-17311
        • Porreca F.
        • Filla A.
        • Burks T.F.
        Studies in vivo with dynorphin-(1-9): Analgesia but not gastrointestinal effects following intrathecal administration to mice.
        Eur J Pharmacol. 1983; 91: 291-294
        • Price T.J.
        • Flores C.M.
        Critical evaluation of the colocalization between calcitonin gene-related peptide, substance P, transient receptor potential vanilloid subfamily type 1 immunoreactivities, and isolectin B4 binding in primary afferent neurons of the rat and mouse.
        J Pain. 2007; 8: 263-272
        • Quang P.N.
        • Schmidt B.L.
        Endothelin-A receptor antagonism attenuates carcinoma-induced pain through opioids in mice.
        J Pain. 2010; 11: 663-671
        • Quang P.N.
        • Schmidt B.L.
        Peripheral endothelin B receptor agonist-induced antinociception involves endogenous opioids in mice.
        Pain. 2010; 149: 254-262
        • Scherrer G.
        • Imamachi N.
        • Cao Y.-Q.
        • Contet C.
        • Mennicken F.
        • O’Donnell D.
        • Kieffer B.L.
        • Basbaum A.I.
        Dissociation of the opioid receptor mechanisms that control mechanical and heat pain.
        Cell. 2009; 137: 1148-1159
        • Sevcik M.A.
        • Ghilardi J.R.
        • Peters C.M.
        • Lindsay T.H.
        • Halvorson K.G.
        • Jonas B.M.
        • Kubota K.
        • Kuskowski M.A.
        • Boustany L.
        • Shelton D.L.
        • Mantyh P.W.
        Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization.
        Pain. 2005; 115: 128-141
        • Shedd D.P.
        • Carl A.
        • Shedd C.
        Problems of terminal head and neck cancer patients.
        Head Neck Surg. 1980; 2: 476-482
        • Sheldon R.J.
        • Riviere P.J.
        • Malarchik M.E.
        • Moseberg H.I.
        • Burks T.F.
        • Porreca F.
        Opioid regulation of mucosal ion transport in the mouse isolated jejunum.
        J Pharmacol Exp Ther. 1990; 253: 144-151
        • Shook J.E.
        • Pelton J.T.
        • Lemcke P.K.
        • Porreca F.
        • Hruby V.J.
        • Burks T.F.
        Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: Identification of mu receptor-related functions.
        J Pharmacol Exp Ther. 1987; 242: 1-7
        • Silverman J.D.
        • Kruger L.
        Selective neuronal glycoconjugate expression in sensory and autonomic ganglia: Relation of lectin reactivity to peptide and enzyme markers.
        J Neurocytol. 1990; 19: 789-801
        • Snider W.D.
        • McMahon S.B.
        Tackling pain at the source: New ideas about nociceptors.
        Neuron. 1998; 20: 629-632
        • Stucky C.L.
        • Lewin G.R.
        Isolectin B(4)-positive and -negative nociceptors are functionally distinct.
        J Neurosci. 1999; 19: 6497-6505
        • Svensson P.
        • Cairns B.E.
        • Wang K.
        • Arendt-Nielsen L.
        Injection of nerve growth factor into human masseter muscle evokes long-lasting mechanical allodynia and hyperalgesia.
        Pain. 2003; 104: 241-247
        • Tarpley J.W.
        • Kohler M.G.
        • Martin W.J.
        The behavioral and neuroanatomical effects of IB4-saporin treatment in rat models of nociceptive and neuropathic pain.
        Brain Research. 2004; 1029: 65-76
        • Tung A.S.
        • Yaksh T.L.
        In vivo evidence for multiple opiate receptors mediating analgesia in the rat spinal cord.
        Brain Res. 1982; 247: 75-83
        • Vellani V.
        • Zachrisson O.
        • McNaughton P.A.
        Functional bradykinin B1 receptors are expressed in nociceptive neurones and are upregulated by the neurotrophin GDNF.
        J Physiol. 2004; 560: 391-401
        • Vulchanova L.
        • Riedl M.S.
        • Shuster S.J.
        • Stone L.S.
        • Hargreaves K.M.
        • Buell G.
        • Surprenant A.
        • North R.A.
        • Elde R.
        P2X3 is expressed by DRG neurons that terminate in inner lamina II.
        Eur J Neurosci. 1998; 10: 3470-3478
        • Wang H.B.
        • Zhao B.
        • Zhong Y.Q.
        • Li K.C.
        • Li Z.Y.
        • Wang Q.
        • Lu Y.J.
        • Zhang Z.N.
        • He S.Q.
        • Zheng H.C.
        • Wu S.X.
        • Hokfelt T.G.
        • Bao L.
        • Zhang X.
        Coexpression of delta- and mu-opioid receptors in nociceptive sensory neurons.
        Proc Natl Acad Sci U S A. 2010; 107: 13117-13122
        • Woodbury C.J.
        • Zwick M.
        • Wang S.
        • Lawson J.J.
        • Caterina M.J.
        • Koltzenburg M.
        • Albers K.M.
        • Koerber H.R.
        • Davis B.M.
        Nociceptors lacking TRPV1 and TRPV2 have normal heat responses.
        J Neurosci. 2004; 24: 6410-6415
        • Ye Y.
        • Dang D.
        • Zhang J.
        • Viet C.T.
        • Lam D.K.
        • Dolan J.C.
        • Gibbs J.L.
        • Schmidt B.L.
        Nerve growth factor links oral cancer progression, pain, and cachexia.
        Mol Cancer Ther. 2011; 10: 1667-1676
        • Zhu Z.
        • Friess H.
        • diMola F.F.
        • Zimmermann A.
        • Graber H.U.
        • Korc M.
        • Buchler M.W.
        Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer.
        J Clin Oncol. 1999; 17: 2419-2428
        • Zwick M.
        • Davis B.M.
        • Woodbury C.J.
        • Burkett J.N.
        • Koerber H.R.
        • Simpson J.F.
        • Albers K.M.
        Glial cell line-derived neurotrophic factor is a survival factor for isolectin B4-positive, but not vanilloid receptor 1-positive, neurons in the mouse.
        J Neurosci. 2002; 22: 4057-4065